Department of Radiology, Kyung Hee University Hospital, 23 Kyungheedae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea.
Abdom Radiol (NY). 2020 Oct;45(10):2950-2959. doi: 10.1007/s00261-019-02156-3.
To investigate the diagnostic performance and prognostic significance of a new criterion for radiologic T4a staging on computed tomography (CT) in patients with advanced gastric cancer (AGC).
Between January 2010 and April 2019, 101 patients with pathologically confirmed gastric cancer were collected. Among them, 53 patients with pathologic T3 and T4a cancers were included in this study. Three reviewers assessed preoperative CT scans for radiologic T staging in two sessions, independently and in consensus at a 2-week interval, while blinded about the pathologic T stage. The radiologic serosal invasion sign was defined as a nodular extension from the outer gastric wall reaching beyond the perigastric vascular plane and adopted as a new CT criterion for T4a cancer. We evaluated the diagnostic performance, interobserver agreement, and prognostic significance of this sign for the postoperative recurrence.
There were 46 pathologic T3 cancers (86.7%) and seven pathologic T4a cancers (13.2%). The diagnostic performance of the radiologic serosal invasion sign in the differentiation between T3 and T4a cancers was as follows: sensitivity, 91.3%; specificity, 71.43%; and accuracy, 88.68% for R1 and sensitivity, 78.26%; specificity, 85.71%; and accuracy, 79.25% for R2. The k-value was 0.64. Among the clinical and pathologic variables, radiologic T4a sign [hazard ratio (HR): 7.96; 95% confidence interval (CI) 2.36-26.86, p = 0.001], pathologic T4a (HR 9.82, 95% CI 2.35-40.95, p = 0.002), tumor size (HR 1.18, 95% CI 1.02-1.35, p = 0.026), and lymphovascular invasion (HR 6.39, 95% CI 1.42-28.75, p = 0.015) were the significant factors for postoperative recurrence.
Radiologic serosal invasion sign is reliable as a new CT criterion for T4a cancer staging in patients with advanced gastric cancer, demonstrating 80% to 88% accuracy. Radiologic serosal invasion sign can also serve as a prognostic factor for postoperative recurrence as well as pathologic T4a stage.
探讨一种新的 CT 影像学 T4a 分期标准在进展期胃癌(AGC)患者中的诊断性能和预后意义。
2010 年 1 月至 2019 年 4 月,共收集了 101 例经病理证实的胃癌患者。其中,53 例病理 T3 和 T4a 癌患者纳入本研究。3 位评估者分别在 2 周间隔的两次会议上独立且达成共识地对术前 CT 扫描进行放射学 T 分期评估,同时对病理 T 分期不知情。胃外膜侵犯征象定义为从胃外壁向外延伸的结节,超出胃周血管平面,并采用该征象作为 T4a 癌的新 CT 标准。我们评估了该征象对术后复发的诊断性能、观察者间一致性和预后意义。
46 例病理 T3 癌(86.7%)和 7 例病理 T4a 癌(13.2%)。在 T3 和 T4a 癌之间,放射学外膜侵犯征象的诊断性能如下:R1 时的敏感性为 91.3%,特异性为 71.43%,准确性为 88.68%;R2 时的敏感性为 78.26%,特异性为 85.71%,准确性为 79.25%。K 值为 0.64。在临床和病理变量中,放射学 T4a 征象[危险比(HR):7.96;95%置信区间(CI)2.36-26.86,p=0.001]、病理 T4a(HR 9.82,95%CI 2.35-40.95,p=0.002)、肿瘤大小(HR 1.18,95%CI 1.02-1.35,p=0.026)和淋巴管血管侵犯(HR 6.39,95%CI 1.42-28.75,p=0.015)是术后复发的显著因素。
放射学外膜侵犯征象作为一种新的 CT 标准,可用于进展期胃癌 T4a 癌分期,其准确率为 80%至 88%。放射学外膜侵犯征象也可作为术后复发和病理 T4a 分期的预后因素。